Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . TONG N TANG BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED 北京 同仁堂 國藥 有限公司 ( Incorporated in Hong Kong with limited liability ) ( Stock Code : 3613 ) ANNOUNCEMENT FINANCIAL INFORMATION ANNOUNCEMENT OF TONG REN TANG TECHNOLOGIES FOR THE FIRST QUARTER OF 2021 The announcement is made by Beijing Tong Ren Tang Chinese Medicine Company Limited ( the " Company " ) pursuant to Part XIVA of the Securities and Futures Ordinance ( Chapter 571 of the Laws of Hong Kong ) and Rule 13.09 of the Rules ( the “ Listing Rules ” ) Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited ( the “ Stock Exchange ” ) . The Company notes that Tong Ren Tang Technologies Co. Ltd. ( “ Tong Ren Tang Technologies ” ) published an announcement today in relation to unaudited financial information of Tong Ren Tang Technologies and its subsidiaries for the three months ended 31 March 2021. For detailed information , please refer to the announcement published by Tong Ren Tang Technologies on the website of the Stock Exchange at www.hkexnews.hk . Tong Ren Tang Technologies is the controlling shareholder ( as defined in the Listing Rules ) of the Company as at the date of the announcement . Tong Ren Tang Technologies ( stock code : 1666 ) is listed on the Main Board of the Stock Exchange . -1 -